1. "Herbal Magic Weight Loss Programs". Herbal Magic. http://www.herbalmagic.com/programs2.php. Retrieved 2011-03-27. 2. "Herbal Magic Inc. Recruiting Quality Franchise Partners". BeTheBoss.ca. March 7, 2008. http://www.betheboss.ca/article.cfm?id=300. Retrieved 2011-03-27. 3. "Herbal Magic Diet Program". Weight Loss Center. http://www.weight-losscenter.net/diet-programs-herbal-magic.html. Retrieved 2011-03-27. 4. Johnson, Erica (February 5, 2010). "Magic in a Bottle?". CBC Marketplace. http://www.cbc.ca/video/#/Shows/Marketplace/ID=1405964153. Retrieved March 16, 2010. 5. Knows, George. "Ingredients in Herbal Weight Loss Supplements." Ingredients in Herbal Weight Loss Supplements. Ezine Articles, 16 Sept. 2006. Web. 22 Feb. 2013 6. Keywords: α-Amylase inhibitor; White kidney bean extract (Phase 2); <span style='font-style: italic'>Phaseolus vulgaris</span>; Safety; Starch blocker; Toxicity 8.Dulloo AG. Strategies to counteract readjustments towards lower metabolic rates during obesity management. Nutrition 1993;9:366– 72. 9.Dulloo AG. Spicing fat for combustion. Br J Nutr 1998;80:493–4. 10. Henry CJK, Emery B. Effects of spiced food on metabolic rate. Hum Nutr Clin Nutr 1986;40C:165–8. 11. Dulloo AG. Ephedrine, xanthines and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. Int J Obes Relat Metab Disord 1993;17:S35–40. 12. Borchardt RT, Huber JA. Catechol-Omethyltransferase: structure-activity relationships for inhibition by flavonoids. J Med Chem 1975;18:120–2. 13. Dulloo AG, Seydoux J, Girardier L. Tealine and thermogenesis: interactions between polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 1996;20(suppl):71(abstr). 14. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness measurements of 481 men and women aged 16–72 years. Br J Nutr 1974;32:77–97. 15. Stagg GV, Millin DJ. The nutritional and therapeutic value of tea—a review. J Sci Food Agric 1975;26:1439–59. 16. Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr 1991;54:963–9. 17. Jequier E, Acheson KJ, Schutz Y. Assessment of energy expenditure and fuel utilization in man. Annu Rev Nutr 1987;7:187–208. 18. Bracco D, Ferrarra JM, Arnaud MJ, Jéquier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 1995;269:E671–8. 19. Dulloo AG, Seydoux J, Girardier L, Chantra P, Vandermander J. Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord (in press). 20. Lee MJ, Wang ZY, Li H, et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 1995;44:393–9. 21. Hollman PCH, Tijburg LBM, Yang CS. Bioavailability of flavonoids from tea. Crit Rev Food Sci Nutr 1997;37:719–38. 22. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167:141–147. 23. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82–96. 24. Joshipura KJ, Ascherio A, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Hennekens CH, Spiegelman D, Willett WC. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA. 1999;282:1233–1239. 25. Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Colditz G, Ascherio A, Rosner B, Spiegelman D, Willett WC. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134:1106 –1114. 26. Rouse IL, Beilin LJ, Armstrong BK, Vandongen R. Bloodpressurelowering effect of a vegetarian diet: controlled trial in normotensive subjects. Lancet. 1983;1:5–10. 27. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–1124. 28. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: metaanalysis of randomised trials. Lancet. 2003;361:2017–2023. 29. Lundberg JO, Feelisch M, Bjorne H, Jansson EA, Weitzberg E. Cardioprotective effects of vegetables: is nitrate the answer? Nitric Oxide. 2006;15:359 –362. 30. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med. 2006;355:2792–2793. 31. Modin A, Bjorne H, Herulf M, Alving K, Weitzberg E, Lundberg JO. Nitrite-derived nitric oxide: a possible mediator of ‘acidicmetabolic’ vasodilation. Acta Physiol Scand. 2001;171:9 –16. 32. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov. 2008;7: 33. Lundberg JO, Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med. 2004;37: 34. Feelisch M, Fernandez BO, Bryan NS, Garcia-Saura MF, Bauer S, Whitlock DR, Ford PC, Janero DR, Rodriguez J, Ashrafian H. Tissue processing of nitrite in hypoxia: an intricate interplay of nitric oxide-generating and scavenging systems. J Biol Chem. 2008;283:33927– 33934. 35. Bryan NS, Fernandez BO, Bauer SM, GarciaSaura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol. 2005;1:290 –297. 36. Hobbs AJ. Soluble guanylate cyclase: the forgotten sibling. Trend Pharmacol Sci. 1997;18:484–491. 29. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427–1434. 37. Forte P, Kneale BJ, Milne E, Chowienczyk PJ, Johnston A, Benjamin N, Ritter JM. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. Hypertension. 1998;32:730 –734. 39. Doel JJ, Benjamin N, Hector MP, Rogers M, Allaker RP. Evaluation of bacterial nitrate reduction in the human oral cavity. Eur J Oral Sci. 2005;113:14 –19. 40. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009; 90:1–10.